Skip to main content
Have a personal or library account? Click to login

Figures & tables

Graphical Abstract: Comparison of vaccination rates in Latin America by region
Figure 1

Distribution of participating countries by region (30).

Table 1

Baseline characteristics of the sample.

VARIABLECENTRAL AMERICA & CARIBBEANANDEAN REGIONSOUTHERN CONEp VALUE
N8,0937,4924,801
Influenza vaccination (n – %)3,304–40.8%3,756–50.1%2,284–47.57%< 0.001
Streptococcus pneumoniae (n-%)2,727–33.7%2,611–34.85%1,498–31.2%0.05
≥ 3 doses COVID-19 (n-%)6,161–76.13%5,948–79.39%3,832–79.82%< 0.001
Female gender (n-%)5,382–66.5%4,647–62.03%3,033–63.17%< 0.001
Mean age (age + STD)45.29 + 17.4845.81 + 16.1746.51 + 16.420.025
Locality of residence
100,000–500,000 inhabitants1,459–18%951–12.69%1,201–25.02%< 0.001
> 500,000 inhabitants2,408–29.75%3,272–43.69%1,866–38.87%< 0.001
Employment relationship
Active6,352–78.49%5,749–70.09%2,963–61.72%< 0.001
Retired1,204–14.88%877–11.71%647–13.48%0.41
Health service
Public2,175–26.87%2,197–21.18%1,847–31.37%< 0.001
Social Security3,750–46.3%3,290–31.72%805–13.67%< 0.001
Cardiovascular risk factors
Hypertension2,858–35.3%1,603–21.4%1,252–26.08%< 0.001
Overweight/Obesity1,681–20.8%1,457–19.45%1,020–21.25%0.07
Dyslipidemia1,143–14.1%1,098–14.66%778–16.2%NS
Diabetes1,082–13.4%451–6.02%573–11.94%NS
Smoking273–3.37%240–3.2%231–5.02%< 0.001
Comorbidities
Coronary artery disease505–6.24%328–4.38%143–2.97%< 0.001
Heart failure296–3.66%250–3.34%78–1.62%< 0.001
Kidney disease172–2.13%159–2.12%73–1.52%< 0.001
Stroke98–1.21%113–1.51%39–0.81%< 0.001
Medication use
None4,155–45.5%4,001–53.4%2,040–42.49%< 0.001
≥ 3 medications2,049–25.48%1,257–16.77%1,074–22.38%< 0.001
Knowledge about cardiovascular benefits of vaccination1,851–22.87%1,793–29.48%971–31.91%< 0.001
Table 2

Multivariate logistic regression for influenza vaccination.

VARIABLE/CATEGORYβ COEFFICIENT95% CI β COEFFICIENTOR95% CIp VALUE
Andean region–0.057–0.172 to 0.0580.9450.842–1.060.335
Central America & Caribbean region–0.111–0.223 to 0.0010.8950.800–1.0010.053
Medical doctors and health and health care workers0.3060.204 to 0.4091.3581.226–1.505< 0.001
Male gender–0.330–0.411 to –0.2490.7190.663–0.780< 0.001
Self-employed worker–0.280–0.386 to –0.1740.7560.679–0.841< 0.001
Mean financial income < US $1,5000.1680.044 to 0.2921.1831.045–1.3990.008
I do not like to take medicines–0.480–0.794 to –0.1670.6190.452–0.8470.003
Yes, I have Influenza0.0990.013 to 0.1861.1041.013–1.2040.025
Confidence on Influenza vaccine ≥71.3821.258 to 1.5073.9853.517–4.515< 0.001
Yes, I have been vaccinated against Streptoccocus Pneumoniae0.6440.567 to 0.7221.9051.763–2.059< 0.001
Family doctor prescribes vaccination0.2160.047 to 0.3851.2411.048–1.4690.012
Cardiologist prescribes vaccination0.5300.295 to 0.7641.6981.343–2.148< 0.001
1-point increase knowledge benefits vaccination0.0480.036 to 0.0601.0491.037–1.061< 0.001
Yes, I know Influenza vaccination season1.0130.928 to 1.0992.7552.528–3.002< 0.001
Yes, there are Influenza and Streptococcus pneumoniae vaccination campaigns in my country0.5220.380 to 0.6631.6851.463–1.941< 0.001
Type 2 Diabetes0.2560.118 to 0.3951.2921.125–1.484< 0.001
Table 3

Multivariate logistic regression for pneumococcal vaccination.

VARIABLE/CATEGORYβ COEFFICIENT95% CI β COEFFICIENTOR95% CIp VALUE
Andean region0.1140.010 to 0.2161.1211.010–1.2440.032
Central America & Caribbean region0.2860.183 to 0.3891.3311,201–1.475< 0.001
Higher education and postgraduate studies0.1320.034 to 0.2301.1411.034–1.2590.009
Medical doctors and health care workers0.1920.098 to 0.2851.2111.103–1.330< 0.001
Age ≤ 60 years–0.412–0.623 to –0.2000.6630.536–0.819< 0.001
Mean financial income < US $1,500–0.341–0.455 to –0.2280.7110.635–0.796< 0.001
Yes, I have Streptococcus pneumoniae0.6540.487 to 0.8211.9241.628–2.273< 0.001
Confidence on Streptococcus pneumoniae vaccine ≥71.4191.292 to 1.5454.1313.641–4.688< 0.001
Pulmonologist prescribes vaccination0.4720.211 to 0.7331.6031.234–2.082< 0.001
Pediatrician prescribes vaccination0.3990.141 to 0.6571.4901.151–1.9290.002
1-point increase knowledge benefits vaccination0.0450.034 to 0.0551.0461.035–1.057< 0.001
Yes, I know Influenza vaccination season0.2020.114 to 0.2891.2231.121–1.335< 0.001
Yes, there are Influenza and Streptococcus pneumoniae vaccination campaigns in my country0.3860.250 to 0.5231.4721.264–1.687< 0.001
Chronic obstructive pulmonary disease0.3890.196 to 0.5811.4751.217–1.788< 0.001
Table 4

Multivariate logistic regression for COVID-19 vaccination.

VARIABLE/CATEGORYβ COEFFICIENT95% CI β COEFFICIENTOR95% CIp VALUE
Andean region–0.093–0.245 to 0.0580.9110.783–1.0590.225
Central America & Caribbean region–0.566–0.707 to –0.4260.5680.493–0.653<0.001
Higher education and postgraduate studies0.1270.013 to 0.2411.1351.013–1.2720.029
Medical doctors and health care workers0.2730.143 to 0.4031.3141.154–1.496<0.001
Living in city <500.000 inhabitants–0.387–0.559 to –0.2140.6790.572–0.807<0.001
Male gender–0.100–0.196 to –0.0040.9050.822–0.9960.041
Self-employed worker–0.286–0.443 to 0.1290.7510.642–0.879<0.001
DOI: https://doi.org/10.5334/gh.1600 | Journal eISSN: 2211-8179 | Journal ISSN: 2211-8160
Language: English
Page range: 81 - 81
Submitted on: Feb 1, 2026
Accepted on: Oct 19, 2026
Published on: Nov 12, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Fernando Wyss, Daniel Piskorz, Ricardo Lopez-Santi, Lucelli Yañez Gutiérrez, Horacio Márquez-Gonzales, Fabio Enrique Parada, Vladimir Ullauri, Ana Munera Echeverri, Juan Esteban Gómez, Osiris Valdez, Máxima Méndez, Claudia Almonte, Carlos Ponte-Negretti, María Alayde Mendoça Rivera, Iván Romero Rivera, Raúl Villar, Jorge Alberto Rivera, Dulman Pineda de Paz, Ana Isabel Barrientos, Edmundo Jordan, Gonzalo Piskorz, Pilar Lopez-Santi, CorVacc study investigators. Cardiovascular Prevention Council (SIAC-PREVENT) of the Inter-American Society of Cardiology (SIAC), published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.